ATC Group: V04CD06 Macimorelin

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V04CD06 in the ATC hierarchy

Level Code Title
1 V Various
2 V04 Diagnostic agents
3 V04C Other diagnostic agents
4 V04CD Tests for pituitary function
5 V04CD06

Active ingredients in V04CD06

Active Ingredient Description
Macimorelin

Macimorelin is an orally available peptidomimetic with growth hormone (GH) secretagogue activity similar to ghrelin. Macimorelin stimulates GH release by activating growth hormone secretagogue receptors (GHSR) present in the pituitary and hypothalamus.

Related product monographs

Title Information Source Document Type  
GHRYVELIN Granules for oral suspension European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Croatia (HR)

Estonia (EE)

France (FR)

Ireland (IE)

Italy (IT)

Lithuania (LT)

Poland (PL)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.